This is a short guide to some of the key legal developments for intellectual property in the life sciences sector in 2013.

The developments include a proposed new EU Clinical Trials Regulation, progress of the EU unitary patent package, the UK Patent Box and R&D tax credit coming into effect, reform of the research and Bolar exceptions and a proposed new EU legislative framework for medical devices. They also include developments relating to database rights, exceptions to copyright law, changes to UK design law and a new EU Regulation on data protection.

For further information or advice, please contact your usual contact at Mayer Brown or any of the Intellectual Property Partners in our London Office whose details can be found at the end of this guide.

Downloads –